AzTrials
AzTrials

Adenoid HypertrophyNCT07856771

Conventional Curettage Versus Endoscopic Microdebrider-Assisted Adenoidectomy in Children

A study testing Conventional Curretage Adenoidectomy and Endoscopic Microdebrider-Assisted Adenoidectomy in people with Adenoid Hypertrophy, run by Allama Iqbal Teaching Hospital at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this randomized clinical trial is to compare two surgical methods for removing enlarged adenoids in children: conventional curettage adenoidectomy and endoscopic microdebrider-assisted adenoidectomy. Read more about this study

Who is it for?
Ages 3 to 16 years
Conditions the study is for
Adenoid Hypertrophy
What is being tested?
Conventional Curretage Adenoidectomy and Endoscopic Microdebrider-Assisted Adenoidectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 sitePakistan
Study dates
1 May 2025to 30 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

None listed.

Who cannot join

  • Craniofacial syndromes (cleft lip, cleft palate)

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Allama Iqbal Teaching Hospital

    Dera Ghazi Khan, Punjab Province, 32200

Other trials in Pakistan

About this study

Official title: A Comparative Study of Conventional Curettage Adenoidectomy Versus Endoscopic Microdebrider-Assisted Adenoidectomy in Children

The purpose of this randomized clinical trial is to compare two surgical methods for removing enlarged adenoids in children: conventional curettage adenoidectomy and endoscopic microdebrider-assisted adenoidectomy. Enlarged adenoids can cause problems such as snoring, mouth breathing, obstructive sleep apnea, and changes in facial appearance.

The main question this study aims to answer is:

Read more
  • Does endoscopic microdebrider-assisted adenoidectomy result in different operative outcomes compared with conventional curettage adenoidectomy?

The study will include 88 children aged 3-16 years who have enlarged adenoids and symptoms such as obstructive sleep apnea, mouth breathing, or snoring. Participants will be randomly assigned to one of two groups:

  • Group A: Adenoidectomy using a conventional adenoid curette.
  • Group B: Adenoidectomy using a microdebrider while viewing the adenoids with an endoscope.

All procedures will be performed under general anesthesia. The researchers will record the duration of the operation and the amount of blood lost during surgery. These outcomes will be compared between the two groups to determine whether the surgical techniques differ in operative time and blood loss.

Parents or guardians will provide informed consent before their child participates in the study.

Being tested
Conventional Curretage Adenoidectomy, Endoscopic Microdebrider-Assisted Adenoidectomy
Keywords
Adenoidectomy, Adenoid Hypertrophy, Endoscopic Adenoidectomy, Microdebrider, Curettage Adenoidectomy, Pediatric Adenoidectomy, Obstructive Sleep Apnea, Snoring, Mouth Breathing, Operative time, Blood loss
Medical subject headings
Sleep Apnea, Obstructive, Snoring, Mouth Breathing, Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional Curretage AdenoidectomyProcedure or surgery

    Surgical removal of enlarged adenoid tissue using a St. Clair Thompson adenoid curette under general anesthesia with orotracheal intubation.

  • Endoscopic Microdebrider-Assisted AdenoidectomyProcedure or surgery

    A 45° angled blade will be introduced through the oropharynx, with irrigation at 15 mL/min and the microdebrider set at 5000 oscillations/second. A zero-degree endoscope will be inserted through either nostril for visualization during the procedure.

Study groups in NCT07856771
Study groupRoleWhat they receive
Conventional Curretage AdenoidectomyActive comparatorParticipants will undergo conventional adenoidectomy using a St. Clair Thompson adenoid curette under general anesthesia with orotracheal intubation.
Receives: Procedure: Conventional Curretage Adenoidectomy
Endoscopic Microdebrider-Assisted AdenoidectomyExperimentalParticipants will undergo adenoidectomy using a microdebrider under endoscopic visualization.
Receives: Procedure: Endoscopic Microdebrider-Assisted Adenoidectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative Blood Loss

    Total blood loss during adenoidectomy, measured from the graduated suction cylinder and by weighing pre-weighed roller packs used in the nasopharynx, with 1 gram of blood equivalent to 1 mL.

    Measured: From the start of surgery until completion of adenoidectomy and handover of the patient to the anesthetist for extubation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2026
  2. Study start1 May 2025
  3. Primary completion30 Oct 2025
  4. Study completion30 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07856771
Sponsor's protocol ID
U1111-1347-4945
Status last verified
Sep 2026
First submitted
28 Sep 2026
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Curretage Adenoidectomy and Endoscopic Microdebrider-Assisted Adenoidectomy in people with Adenoid Hypertrophy, run by Allama Iqbal Teaching Hospital at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative Blood Loss (time frame: From the start of surgery until completion of adenoidectomy and handover of the patient to the anesthetist for extubation.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in